Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3139423 | 0.78 | — | — | |
| SCHEMBL9165611 | 0.75 | TSHR (0.31) | TSHRTDP1 | |
| SCHEMBL27575640 | 0.75 | TSHR (0.31) | TSHRTDP1 | |
| SCHEMBL27541974 | 0.73 | — | — | |
| SCHEMBL18973983 | 0.69 | TSHR (0.31) | TSHR | |
| SCHEMBL18973954 | 0.69 | TSHR (0.31) | TSHR | |
| SCHEMBL27551463 | 0.69 | USP2 (0.33) | — | |
| SCHEMBL3084592 | 0.68 | TSHR (0.30) | TSHR | |
| SCHEMBL27394581 | 0.67 | ALDH1A1 (0.31) | — | |
| SCHEMBL28343870 | 0.67 | TDP1 (0.37) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238251-A9 | A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof | ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) | 2024-07-18 | — | — | US | claimed |
| WO-2024146964-A1 | METHOD OF PREPARING MICROPARTICLES, PHARMACEUTICAL POLYMERIC COMPOSITIONS, ACTIVE INGREDIENT DELIVERY MEDICAL DEVICE AND IMPLANT | BODMEIER ROLAND (DE) | 2024-07-11 | — | — | WO | claimed |
| US-20230404909-A1 | MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN | LEO PHARMA AS (DK) | 2023-12-21 | — | — | US | claimed |
| US-20230390245-A1 | A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof | SHANGHAI YASHENG PHARMACEUTICAL TECH CO LTD (CN) | 2023-12-07 | — | — | US | claimed |
| CN-116799213-A | Lithium ion battery positive electrode slurry dispersion auxiliary agent and preparation method and application thereof | 江西安驰新能源科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| EP-4240330-A1 | A COMPOSITION COMPRISING HETEROCYCLIC COMPOUNDS, PREPARATION METHOD AND APPLICATION THEREOF | Shanghai Yasheng Pharmaceutical Technology Co., Ltd. (CN) | 2023-09-13 | — | — | EP | claimed |
| WO-2022095894-A1 | A COMPOSITION COMPRISING HETEROCYCLIC COMPOUNDS, PREPARATION METHOD AND APPLICATION THEREOF | Shanghai Yasheng Pharmaceutical Technology Co., Ltd. (CN) | 2022-05-12 | — | — | WO | claimed |
| CN-113842376-A | Risperidone-containing pharmaceutical composition, oral dissolving film agent and preparation method | 齐鲁制药有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-107405301-B | Microneedle patch for delivering active ingredients to the skin | 利奥制药有限公司 | 2021-11-30 | — | — | CN | claimed |
| EP-3273942-B1 | MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO THE SKIN | LEO PHARMA AS (DK) | 2021-06-16 | — | — | EP | claimed |
| WO-2004011054-A2 | INJECTABLE MULTIMODAL POLYMER DEPOT COMPOSITIONS AND USES THEREOF | ALZA CORPORATION (US) | 2004-02-05 | — | — | WO | claimed |
| US-6673767-B1 | DRUG DELIVERY USING TIME-RELEASE AGENTS COMPRISINGS POLYLACTIC ACID, PLASTICIZER SOLVENTS SELECTED FROM BENZYL OR ETHYL BENZOATE AND CDNA, DNA, PROTEINS, PEPTIDES AND/OR ANTICARCINOGENIC AGENTS | ALZA CORPORATION | 2004-01-06 | — | — | US | claimed |
| US-20030211974-A1 | Gel composition and methods | DURECT CORPORATION | 2003-11-13 | — | — | US | claimed |
| US-20030044467-A1 | Gel composition and methods | DURECT CORPORATION | 2003-03-06 | — | — | US | claimed |
| US-6468961-B1 | IMPLANTABLE COMPOSITION FOR SUSTAINED DELIVERY OF BENEFICIAL AGENT COMPRISING POLYLACTIDE POLYMER, AMOUNT OF SOLVENT COMPRISING LOWER ALKYL OR ARALKYL ESTER OF BENZOIC ACID EFFECTIVE TO FORM VISCOUS GEL, BENEFICIAL AGENT | ALZA CORPORATION | 2002-10-22 | — | — | US | claimed |
| US-6130200-A | Gel composition and methods | ALZA CORPORATION (US) | 2000-10-10 | — | — | US | claimed |
| EP-0959873-A2 | GEL COMPOSITION AND METHODS | ALZA CORPORATION (US) | 1999-12-01 | — | — | EP | claimed |
| WO-1998027963-A2 | GEL COMPOSITION AND METHODS | ALZA CORPORATION (US) | 1998-07-02 | — | — | WO | claimed |
| US-5705196-A | Process of continuous preparation of disperse colloidal systems in the form of nanocapsules or nanoparticles | LABORATORIOS CUSI, S.A. (ES) | 1998-01-06 | — | — | US | claimed |
| US-H1565-H | Superabsorbent, continuous filament web | DEUTSCHE BANK AG, NEW YORK BRANCH | 1996-07-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390245-A1 | A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof | ABCG2, AP1G1, ALPI | TSHR 3673/4885TDP1 3996/4885 |
| US-20230404909-A1 | MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN | MMP1, MMP17, CUTA | TSHR 4023/4885TDP1 2657/4885 |
| US-20030211974-A1 | Gel composition and methods | CXCL8, MMP1, BMP2 | TSHR 4201/4885TDP1 1301/4885 |
| US-20240238251-A9 | A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof | ABCG2, AP1G1, ALPI | TSHR 3673/4885TDP1 3996/4885 |
| US-20030044467-A1 | Gel composition and methods | CXCL8, MMP1, BMP2 | TSHR 4201/4885TDP1 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.